Sorafenib Recruiting Phase 2 Trials for Malignant Gliomas / Gliomas / Glioblastomas / Brain and Nervous System / WHO Grade III Glioma / Recurrent Adult Brain Neoplasm Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01817751Sorafenib Tosylate, Valproic Acid, and Sildenafil Citrate in Treating Patients With Recurrent High-Grade Glioma